Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

1-trityl-4-nitroimidazole

E Skrzypczak-Jankun1, R G Kurumbail

  • 1Department of Chemistry, University of Toledo, OH 43606, USA.

Acta Crystallographica. Section C, Crystal Structure Communications
|January 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allosteric Modulation of AMPK Enzymatic Activity: In Vitro Characterization.

Methods in enzymology·2017
Same author

Human lipoxygenase: developments in its structure, function, relevance to diseases and challenges in drug development.

Current medicinal chemistry·2012
Same author

Val17Ile single nucleotide polymorphisms similarly as Ala15Thr could be related to the lower secretory dynamics of PAI-1 secretion: theoretical evidence.

Current molecular medicine·2011
Same author

Eicosanoids in prevention and management of diseases.

Current molecular medicine·2010
Same author

Effect of crystal freezing and small-molecule binding on internal cavity size in a large protein: X-ray and docking studies of lipoxygenase at ambient and low temperature at 2.0 A resolution.

Acta crystallographica. Section D, Biological crystallography·2006
Same author

Aspirin blocks binding of photosensitizer SnET2 into human serum albumin: implications for photodynamic therapy.

International journal of molecular medicine·2005

X-ray analysis confirmed the structure of a novel N1-alkylated C4-nitroimidazole inhibitor. Molecular modeling revealed that C4 substituents hinder interactions with cytochrome P450, reducing inhibitor effectiveness.

Area of Science:

  • Medicinal Chemistry
  • Structural Biology
  • Pharmacology

Background:

  • Cytochrome P450 enzymes are crucial drug metabolizers.
  • N1-alkylated nitroimidazoles are investigated as potential enzyme inhibitors.
  • Understanding structure-activity relationships is key for drug design.

Purpose of the Study:

  • To elucidate the precise molecular configuration of a novel N1-alkylated C4-nitroimidazole inhibitor.
  • To model the interactions between this inhibitor and cytochrome P450 enzymes.
  • To explain the impact of C4 substitution on inhibitor efficacy.

Main Methods:

  • X-ray crystallography was employed to determine the inhibitor's structure.
  • Molecular modeling was performed using crystal structures of cytochrome P450BM-3 and 1-trityl-4-nitroimidazole.

Related Experiment Videos

  • Sequence modifications were made to bacterial P450 to simulate mammalian P450-IIIA1.

    • Main Results:

    • X-ray analysis confirmed the inhibitor's N1-alkylation and C4-nitroimidazole configuration.
    • The imidazole ring plane bisects the angle between two phenyl rings, with the nitro group positioned over the third.
    • Modeling indicated that C4 substituents impede close interactions between the imidazole ring and the heme iron atom of cytochrome P450.

    Conclusions:

    • The study provides definitive structural confirmation of the N1-alkylated C4-nitroimidazole inhibitor.
    • Molecular modeling successfully explains the reduced efficacy of C4-substituted inhibitors.
    • These findings offer insights into the rational design of more potent cytochrome P450 inhibitors.